LILLY (ELI) & CO's gross profit margin for the first quarter of its fiscal year 2015 has decreased when compared to the same period a year ago. Sales and net income have dropped, although the growth in net income underperformed the average competitor within the industry, the revenue growth did not.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY15||Q1 FY14|
|Net Sales ($mil)||4644.7||4683.1|
|Net Income ($mil)||529.5||727.9|
|Balance Sheet||Q1 FY15||Q1 FY14|
|Cash & Equiv. ($mil)||0.0||5212.4|
|Total Assets ($mil)||0.0||34756.9|
|Total Debt ($mil)||0.0||5264.4|
|Profitability||Q1 FY15||Q1 FY14|
|Gross Profit Margin||75.69||81.34|
|Return on Assets||0.0||11.11|
|Return on Equity||0.0||21.07|
|Debt||Q1 FY15||Q1 FY14|
|Share Data||Q1 FY15||Q1 FY14|
|Shares outstanding (mil)||1060.63||1069.45|
|Div / share||0.5||0.49|
|Book value / share||0.0||17.15|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||4347675.0||4584514.0|
BUY. This stock's P/E ratio indicates a premium compared to an average of 32.75 for the Pharmaceuticals industry and a significant premium compared to the S&P 500 average of 20.38. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average.
|LLY 35.06||Peers 32.75||LLY NA||Peers 45.92|
Average. An average P/E ratio can signify an industry neutral price for a stock and an average growth expectation.
LLY is trading at a valuation on par with its peers.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|LLY 20.48||Peers 17.68||LLY 0.85||Peers 1.28|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
LLY is trading at a significant premium to its peers.
Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
LLY trades at a significant discount to its peers.
|LLY NA||Peers 8.21||LLY -42.58||Peers 9.32|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
Ratio not available.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, LLY is expected to significantly trail its peers on the basis of its earnings growth rate.
|LLY 3.89||Peers 6.64||LLY -11.80||Peers 11.98|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
LLY is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
LLY significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV